CLPT
ClearPoint Neuro, Inc.Company Information
- Company Name
- ClearPoint Neuro, Inc.
- CIK
- CIK0001285550
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CLPT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- CLPT
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-06-29
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 175,863
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,786,067
- Shares outstanding
- 30,166,640
- Ownership
- 45.70%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 1.11%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 29 | 36 | 46 | 38 | 42 | 12 | 20 | 22 | 33 | 35 | 23 | 24 | ||||||
| Accounts Receivable Net Current | 8 | 9 | 7 | 4 | 4 | 4 | 5 | 4 | 3 | 3 | 3 | 2 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Inventory Net | 9 | 9 | 8 | 7 | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Assets Current | 49 | 55 | 64 | 51 | 54 | 24 | 33 | 34 | 47 | 48 | 36 | 37 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 13 | 13 | 8 | 6 | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Inventory Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Indefinite Lived Contractual Rights | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Goodwill | 7 | 7 | 7 | - | - | - | 0 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 13 | 13 | 14 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 2 | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 87 | 93 | 98 | 60 | 63 | 30 | 39 | 40 | 53 | 54 | 43 | 44 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Employee Related Liabilities Current | 4 | 3 | 4 | 4 | 3 | 2 | 5 | 4 | 3 | 2 | 3 | 2 | ||||||
| Other Accrued Liabilities Current | 2 | 2 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | 2 | 1 | 1 | 1 | 3 | 1 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 10 | 10 | - | - | ||||||
| Contract With Customer Liability Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | - | - | - | - | - | ||||||
| Liabilities Current | 10 | 9 | 11 | 8 | 7 | 7 | 10 | 8 | 17 | 15 | 7 | 6 | ||||||
| Operating Lease Liability Noncurrent | 14 | 14 | 8 | 6 | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | - | - | - | - | - | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 10 | 10 | ||||||
| Long Term Notes Payable | 50 | 50 | 49 | 29 | 29 | - | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities | 76 | 75 | 70 | 44 | 43 | 10 | 14 | 11 | 20 | 19 | 21 | 20 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 246 | 239 | 239 | 225 | 223 | 217 | 216 | 215 | 213 | 211 | 193 | 192 | ||||||
| Common Stock Shares Subscriptions | 3 | 6 | 6 | - | - | - | 0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -238 | -226 | -217 | -209 | -203 | -197 | -191 | -186 | -181 | -177 | -172 | -168 | ||||||
| Stockholders Equity | 11 | 19 | 28 | 16 | 20 | 20 | 25 | 29 | 32 | 35 | 21 | 24 | ||||||
| Liabilities And Stockholders Equity | 87 | 93 | 98 | 60 | 63 | 30 | 39 | 40 | 53 | 54 | 43 | 44 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | ||||||
| Common Stock Shares Issued | 31 | 30 | 29 | 28 | 28 | 28 | 28 | 28 | 28 | 27 | 25 | 25 | ||||||
| Shares Outstanding | 31 | 30 | 29 | 28 | 28 | 28 | 28 | 28 | 28 | 27 | 25 | 25 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialClearPoint Neuro, Inc. (CLPT) — SEC Financial Statements & Analysis
ClearPoint Neuro, Inc. (CLPT) is a surgical & medical instruments & apparatus company, incorporated in DE. ClearPoint Neuro, Inc. trades on Nasdaq as: CLPT. ClearPoint Neuro, Inc. (CLPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, ClearPoint Neuro, Inc. carries a market cap of $538.17M, a P/E ratio of -15.57x, a P/B ratio of 49.94x, a P/S ratio of 12.73x, an enterprise value of $558.12M, and an EV/EBITDA multiple of -18.30x. On profitability, it posts a gross margin of 62.61%, an operating margin of -73.42%, a net margin of -81.76%, a Return on Equity (ROE) of -226.52%, a Return on Assets (ROA) of -46.21%, and a Return on Invested Capital (ROIC) of -158.69%. Per share, it reports EPS of $-1.15, diluted EPS of $-1.15, free cash flow per share of $-1.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 25.86% year-over-year, net income growth of 55.54% year-over-year, and EPS growth of 45.70% year-over-year. On the balance sheet, it maintains a current ratio of 4.74x, a quick ratio of 3.66x, working capital of $38.62M, a debt-to-equity ratio of 7.05x, a debt ratio of 0.88, an interest coverage ratio of -9.30x, free cash flow of $-31.29M (TTM), and net debt of $19.94M. Figures sourced from SEC EDGAR.
- Market Cap
- $538.17M
- P/E TTM
- -15.57x
- EPS TTM
- $-1.15
- P/B TTM
- 49.94x
- ROE TTM
- -226.52%
- ROA TTM
- -46.21%
- Debt To Equity
- 7.05x
- Free Cash Flow TTM
- $-31.29M
- Net Revenue TTM Growth 1Y
- 25.86%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ClearPoint Neuro, Inc. in?
ClearPoint Neuro, Inc. (CLPT) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does CLPT trade on?
ClearPoint Neuro, Inc. (CLPT) trades on the Nasdaq.
Where is ClearPoint Neuro, Inc. incorporated?
ClearPoint Neuro, Inc. is incorporated in DE.
When was ClearPoint Neuro, Inc. (CLPT)'s most recent SEC filing?
ClearPoint Neuro, Inc. (CLPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is CLPT's market cap?
ClearPoint Neuro, Inc. (CLPT) has a market capitalization of $538.17M as of 2026-06-30.
What is CLPT's EPS (earnings per share)?
ClearPoint Neuro, Inc. (CLPT)'s trailing twelve month EPS is $-1.15 as of 2026-06-30.
What is CLPT's ROE (return on equity)?
ClearPoint Neuro, Inc. (CLPT)'s trailing twelve month Return on Equity (ROE) is -226.52% as of 2026-06-30.
What is CLPT's ROA (return on assets)?
ClearPoint Neuro, Inc. (CLPT)'s trailing twelve month Return on Assets (ROA) is -46.21% as of 2026-06-30.
What is CLPT's ROIC (return on invested capital)?
ClearPoint Neuro, Inc. (CLPT)'s trailing twelve month Return on Invested Capital (ROIC) is -158.69% as of 2026-06-30.
What is CLPT's EV/EBITDA?
ClearPoint Neuro, Inc. (CLPT)'s trailing twelve month EV/EBITDA is -18.30x as of 2026-06-30.